We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
+13.13%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$1.11B
AUM Growth
+$28.9M
Cap. Flow
-$70.4M
Cap. Flow %
-6.34%
Top 10 Hldgs %
20.71%
Holding
564
New
93
Increased
113
Reduced
193
Closed
56

Sector Composition

Rank Sector Weight
1 Technology 12.92%
2 Financials 9.74%
3 Healthcare 8.27%
4 Industrials 8.16%
5 Consumer Discretionary 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNY icon
451
Sanofi
SNY
$109B
$10K ﹤0.01%
200
HSBC.PRA
452
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$10K ﹤0.01%
400
BRK.B icon
453
Berkshire Hathaway Class B
BRK.B
$1.08T
$9K ﹤0.01%
40
MUNI icon
454
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.14B
$8K ﹤0.01%
133
OMF icon
455
OneMain Financial
OMF
$7.26B
$8K ﹤0.01%
169
-188
-53% -$7.42K
VKQ icon
456
Invesco Municipal Trust
VKQ
$541M
$8K ﹤0.01%
600
-400
-40% -$4.97K
BAC.PRE icon
457
Bank of America Depository Shares Series E
BAC.PRE
$1.46B
$7K ﹤0.01%
259
-26
-9% -$650
DLR icon
458
Digital Realty Trust
DLR
$71.8B
$7K ﹤0.01%
50
-9,950
-100% -$1.42M
THC icon
459
Tenet Healthcare
THC
$22.1B
$7K ﹤0.01%
167
-185
-53% -$5.97K
VNM icon
460
VanEck Vietnam ETF
VNM
$525M
$7K ﹤0.01%
400
AOSL icon
461
Alpha and Omega Semiconductor
AOSL
$793M
$6K ﹤0.01%
250
JETS icon
462
US Global Jets ETF
JETS
$799M
$6K ﹤0.01%
+267
New +$5.38K
PAVE icon
463
Global X US Infrastructure Development ETF
PAVE
$13.8B
$6K ﹤0.01%
+277
New +$5.38K
PDBC icon
464
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.93B
$6K ﹤0.01%
+400
New +$5.69K
ISTB icon
465
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.09B
$5K ﹤0.01%
+100
New +$5.15K
VGT icon
466
Vanguard Information Technology ETF
VGT
$145B
$5K ﹤0.01%
120
VIRC icon
467
Virco
VIRC
$95.5M
$5K ﹤0.01%
2,000
TRTN
468
DELISTED
Triton International Limited
TRTN
$5K ﹤0.01%
99
-150
-60% -$6.34K
GLUU
469
DELISTED
Glu Mobile Inc.
GLUU
$5K ﹤0.01%
+602
New +$5.19K
ARGX icon
470
argenx
ARGX
$65.5B
$4K ﹤0.01%
12
-36
-75% -$9.9K
TFI icon
471
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.1B
$4K ﹤0.01%
83
TTGT icon
472
TechTarget
TTGT
$281M
$4K ﹤0.01%
+65
New +$3.36K
ALSN icon
473
Allison Transmission
ALSN
$10.6B
$3K ﹤0.01%
67
-102
-60% -$4.1K
FSI icon
474
Flexible Solutions
FSI
$73.1M
$3K ﹤0.01%
1,100
VCR icon
475
Vanguard Consumer Discretionary ETF
VCR
$6.04B
$3K ﹤0.01%
12
+3
+33% +$762

Similar funds

James Investment Research's Q4 2020 Portfolio in Review

As of Q4 2020, James Investment Research held 564 positions worth $1.11B, up 2.7% from $1.08B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

James Investment Research withdrew a net $70.4M in Q4 2020, closing 56 positions and reducing 193 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $4.67M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, James Investment Research opened a new position in Vanguard Morningstar Small-Cap Value ETF worth $15.4M.

  • James Investment Research's largest Q4 2020 buy was Vanguard Morningstar Small-Cap Value ETF: 108,050 shares worth $15.4M.
  • James Investment Research added most to iShares Russell 2000 Value ETF in Q4 2020, an estimated $15.2M increase.
  • James Investment Research's biggest Q4 2020 reduction was Microsoft, cutting an estimated $11.7M.
  • James Investment Research fully exited Regeneron Pharmaceuticals in Q4 2020, selling an estimated $4.67M.
  • James Investment Research's ten largest holdings make up 21% of its $1.11B portfolio in Q4 2020.
  • James Investment Research opened 93 new positions and closed 56 in Q4 2020.
  • James Investment Research's portfolio value rose 2.7% quarter-over-quarter to $1.11B.

Based on James Investment Research's 13F filing for Q4 2020, filed 27 Jan 2021.